Hyundai Bioscience will begin a clinical trial with Seoul National University Hospital to identify the cause of drug resistance raised during prostate cancer treatment. Hyundai Bioscience said on the ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results